Lanolin Alcohol
Lanolin Alcohol market is segmented by Type and by Application. Players, stakeholders, and other ... Read More
Global Biosimilars Market Insights and Forecast to 2028
1 Study Coverage
1.1 Biosimilars Product Introduction
1.2 Market by Type
1.2.1 Global Biosimilars Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Recombinant Glycosylated Proteins
1.3 Market by Application
1.3.1 Global Biosimilars Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Blood Disorders
1.3.4 Growth Hormonal Deficiency
1.3.5 Chronic and Autoimmune Disorders
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biosimilars Sales Estimates and Forecasts 2017-2028
2.2 Global Biosimilars Revenue Estimates and Forecasts 2017-2028
2.3 Global Biosimilars Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Biosimilars Sales by Region
2.4.1 Global Biosimilars Sales by Region (2017-2022)
2.4.2 Global Sales Biosimilars by Region (2023-2028)
2.5 Global Biosimilars Revenue by Region
2.5.1 Global Biosimilars Revenue by Region (2017-2022)
2.5.2 Global Biosimilars Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Biosimilars Sales by Manufacturers
3.1.1 Global Top Biosimilars Manufacturers by Sales (2017-2022)
3.1.2 Global Biosimilars Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biosimilars in 2021
3.2 Global Biosimilars Revenue by Manufacturers
3.2.1 Global Biosimilars Revenue by Manufacturers (2017-2022)
3.2.2 Global Biosimilars Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Biosimilars Revenue in 2021
3.3 Global Biosimilars Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Biosimilars Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biosimilars Sales by Type
4.1.1 Global Biosimilars Historical Sales by Type (2017-2022)
4.1.2 Global Biosimilars Forecasted Sales by Type (2023-2028)
4.1.3 Global Biosimilars Sales Market Share by Type (2017-2028)
4.2 Global Biosimilars Revenue by Type
4.2.1 Global Biosimilars Historical Revenue by Type (2017-2022)
4.2.2 Global Biosimilars Forecasted Revenue by Type (2023-2028)
4.2.3 Global Biosimilars Revenue Market Share by Type (2017-2028)
4.3 Global Biosimilars Price by Type
4.3.1 Global Biosimilars Price by Type (2017-2022)
4.3.2 Global Biosimilars Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Biosimilars Sales by Application
5.1.1 Global Biosimilars Historical Sales by Application (2017-2022)
5.1.2 Global Biosimilars Forecasted Sales by Application (2023-2028)
5.1.3 Global Biosimilars Sales Market Share by Application (2017-2028)
5.2 Global Biosimilars Revenue by Application
5.2.1 Global Biosimilars Historical Revenue by Application (2017-2022)
5.2.2 Global Biosimilars Forecasted Revenue by Application (2023-2028)
5.2.3 Global Biosimilars Revenue Market Share by Application (2017-2028)
5.3 Global Biosimilars Price by Application
5.3.1 Global Biosimilars Price by Application (2017-2022)
5.3.2 Global Biosimilars Price Forecast by Application (2023-2028)
6 North America
6.1 North America Biosimilars Market Size by Type
6.1.1 North America Biosimilars Sales by Type (2017-2028)
6.1.2 North America Biosimilars Revenue by Type (2017-2028)
6.2 North America Biosimilars Market Size by Application
6.2.1 North America Biosimilars Sales by Application (2017-2028)
6.2.2 North America Biosimilars Revenue by Application (2017-2028)
6.3 North America Biosimilars Market Size by Country
6.3.1 North America Biosimilars Sales by Country (2017-2028)
6.3.2 North America Biosimilars Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Biosimilars Market Size by Type
7.1.1 Europe Biosimilars Sales by Type (2017-2028)
7.1.2 Europe Biosimilars Revenue by Type (2017-2028)
7.2 Europe Biosimilars Market Size by Application
7.2.1 Europe Biosimilars Sales by Application (2017-2028)
7.2.2 Europe Biosimilars Revenue by Application (2017-2028)
7.3 Europe Biosimilars Market Size by Country
7.3.1 Europe Biosimilars Sales by Country (2017-2028)
7.3.2 Europe Biosimilars Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Biosimilars Market Size by Type
8.1.1 Asia Pacific Biosimilars Sales by Type (2017-2028)
8.1.2 Asia Pacific Biosimilars Revenue by Type (2017-2028)
8.2 Asia Pacific Biosimilars Market Size by Application
8.2.1 Asia Pacific Biosimilars Sales by Application (2017-2028)
8.2.2 Asia Pacific Biosimilars Revenue by Application (2017-2028)
8.3 Asia Pacific Biosimilars Market Size by Region
8.3.1 Asia Pacific Biosimilars Sales by Region (2017-2028)
8.3.2 Asia Pacific Biosimilars Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Biosimilars Market Size by Type
9.1.1 Latin America Biosimilars Sales by Type (2017-2028)
9.1.2 Latin America Biosimilars Revenue by Type (2017-2028)
9.2 Latin America Biosimilars Market Size by Application
9.2.1 Latin America Biosimilars Sales by Application (2017-2028)
9.2.2 Latin America Biosimilars Revenue by Application (2017-2028)
9.3 Latin America Biosimilars Market Size by Country
9.3.1 Latin America Biosimilars Sales by Country (2017-2028)
9.3.2 Latin America Biosimilars Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Biosimilars Market Size by Type
10.1.1 Middle East and Africa Biosimilars Sales by Type (2017-2028)
10.1.2 Middle East and Africa Biosimilars Revenue by Type (2017-2028)
10.2 Middle East and Africa Biosimilars Market Size by Application
10.2.1 Middle East and Africa Biosimilars Sales by Application (2017-2028)
10.2.2 Middle East and Africa Biosimilars Revenue by Application (2017-2028)
10.3 Middle East and Africa Biosimilars Market Size by Country
10.3.1 Middle East and Africa Biosimilars Sales by Country (2017-2028)
10.3.2 Middle East and Africa Biosimilars Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Biocon
11.3.1 Biocon Corporation Information
11.3.2 Biocon Overview
11.3.3 Biocon Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Biocon Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biocon Recent Developments
11.4 Biogen
11.4.1 Biogen Corporation Information
11.4.2 Biogen Overview
11.4.3 Biogen Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biogen Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biogen Recent Developments
11.5 Fresenius Kabi AG
11.5.1 Fresenius Kabi AG Corporation Information
11.5.2 Fresenius Kabi AG Overview
11.5.3 Fresenius Kabi AG Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Fresenius Kabi AG Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Fresenius Kabi AG Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Overview
11.6.3 Boehringer Ingelheim Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Boehringer Ingelheim Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Recent Developments
11.7 Merck KgaA
11.7.1 Merck KgaA Corporation Information
11.7.2 Merck KgaA Overview
11.7.3 Merck KgaA Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck KgaA Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck KgaA Recent Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Overview
11.8.3 Mylan Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mylan Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mylan Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 Teva Pharmaceutical
11.10.1 Teva Pharmaceutical Corporation Information
11.10.2 Teva Pharmaceutical Overview
11.10.3 Teva Pharmaceutical Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teva Pharmaceutical Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Pharmaceutical Recent Developments
11.11 Dr. Reddy's Laboratories
11.11.1 Dr. Reddy's Laboratories Corporation Information
11.11.2 Dr. Reddy's Laboratories Overview
11.11.3 Dr. Reddy's Laboratories Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Dr. Reddy's Laboratories Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Dr. Reddy's Laboratories Recent Developments
11.12 Amgen
11.12.1 Amgen Corporation Information
11.12.2 Amgen Overview
11.12.3 Amgen Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Amgen Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Amgen Recent Developments
11.13 Celltrion
11.13.1 Celltrion Corporation Information
11.13.2 Celltrion Overview
11.13.3 Celltrion Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Celltrion Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Celltrion Recent Developments
11.14 Samsung Biologics
11.14.1 Samsung Biologics Corporation Information
11.14.2 Samsung Biologics Overview
11.14.3 Samsung Biologics Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Samsung Biologics Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Samsung Biologics Recent Developments
11.15 Roche
11.15.1 Roche Corporation Information
11.15.2 Roche Overview
11.15.3 Roche Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Roche Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Roche Recent Developments
11.16 Probiomed
11.16.1 Probiomed Corporation Information
11.16.2 Probiomed Overview
11.16.3 Probiomed Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Probiomed Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Probiomed Recent Developments
11.17 Apotex
11.17.1 Apotex Corporation Information
11.17.2 Apotex Overview
11.17.3 Apotex Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Apotex Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Apotex Recent Developments
11.18 Chong Kun Dang
11.18.1 Chong Kun Dang Corporation Information
11.18.2 Chong Kun Dang Overview
11.18.3 Chong Kun Dang Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Chong Kun Dang Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Chong Kun Dang Recent Developments
11.19 JCR Pharmaceuticals
11.19.1 JCR Pharmaceuticals Corporation Information
11.19.2 JCR Pharmaceuticals Overview
11.19.3 JCR Pharmaceuticals Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 JCR Pharmaceuticals Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 JCR Pharmaceuticals Recent Developments
11.20 Gan & Lee Pharmaceuticals
11.20.1 Gan & Lee Pharmaceuticals Corporation Information
11.20.2 Gan & Lee Pharmaceuticals Overview
11.20.3 Gan & Lee Pharmaceuticals Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Gan & Lee Pharmaceuticals Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Gan & Lee Pharmaceuticals Recent Developments
11.21 Gedeon Richter
11.21.1 Gedeon Richter Corporation Information
11.21.2 Gedeon Richter Overview
11.21.3 Gedeon Richter Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Gedeon Richter Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Gedeon Richter Recent Developments
11.22 Biocad
11.22.1 Biocad Corporation Information
11.22.2 Biocad Overview
11.22.3 Biocad Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Biocad Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Biocad Recent Developments
11.23 Coherus Bioscience
11.23.1 Coherus Bioscience Corporation Information
11.23.2 Coherus Bioscience Overview
11.23.3 Coherus Bioscience Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Coherus Bioscience Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Coherus Bioscience Recent Developments
11.24 Stada Arzneimittel AG
11.24.1 Stada Arzneimittel AG Corporation Information
11.24.2 Stada Arzneimittel AG Overview
11.24.3 Stada Arzneimittel AG Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Stada Arzneimittel AG Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Stada Arzneimittel AG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biosimilars Industry Chain Analysis
12.2 Biosimilars Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biosimilars Production Mode & Process
12.4 Biosimilars Sales and Marketing
12.4.1 Biosimilars Sales Channels
12.4.2 Biosimilars Distributors
12.5 Biosimilars Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Biosimilars Industry Trends
13.2 Biosimilars Market Drivers
13.3 Biosimilars Market Challenges
13.4 Biosimilars Market Restraints
14 Key Findings in The Global Biosimilars Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Biosimilars Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Table 3. Major Manufacturers of Recombinant Glycosylated Proteins
Table 4. Global Biosimilars Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Biosimilars Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Biosimilars Sales by Region (2017-2022) & (K MT)
Table 7. Global Biosimilars Sales Market Share by Region (2017-2022)
Table 8. Global Biosimilars Sales by Region (2023-2028) & (K MT)
Table 9. Global Biosimilars Sales Market Share by Region (2023-2028)
Table 10. Global Biosimilars Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Biosimilars Revenue Market Share by Region (2017-2022)
Table 12. Global Biosimilars Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Biosimilars Revenue Market Share by Region (2023-2028)
Table 14. Global Biosimilars Sales by Manufacturers (2017-2022) & (K MT)
Table 15. Global Biosimilars Sales Share by Manufacturers (2017-2022)
Table 16. Global Biosimilars Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Biosimilars Revenue Share by Manufacturers (2017-2022)
Table 18. Biosimilars Price by Manufacturers (2017-2022) &(USD/MT)
Table 19. Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars as of 2021)
Table 21. Biosimilars Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Biosimilars Product Offered
Table 23. Date of Manufacturers Enter into Biosimilars Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biosimilars Sales by Type (2017-2022) & (K MT)
Table 26. Global Biosimilars Sales by Type (2023-2028) & (K MT)
Table 27. Global Biosimilars Sales Share by Type (2017-2022)
Table 28. Global Biosimilars Sales Share by Type (2023-2028)
Table 29. Global Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Biosimilars Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Biosimilars Revenue Share by Type (2017-2022)
Table 32. Global Biosimilars Revenue Share by Type (2023-2028)
Table 33. Biosimilars Price by Type (2017-2022) & (USD/MT)
Table 34. Global Biosimilars Price Forecast by Type (2023-2028) & (USD/MT)
Table 35. Global Biosimilars Sales by Application (2017-2022) & (K MT)
Table 36. Global Biosimilars Sales by Application (2023-2028) & (K MT)
Table 37. Global Biosimilars Sales Share by Application (2017-2022)
Table 38. Global Biosimilars Sales Share by Application (2023-2028)
Table 39. Global Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Biosimilars Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Biosimilars Revenue Share by Application (2017-2022)
Table 42. Global Biosimilars Revenue Share by Application (2023-2028)
Table 43. Biosimilars Price by Application (2017-2022) & (USD/MT)
Table 44. Global Biosimilars Price Forecast by Application (2023-2028) & (USD/MT)
Table 45. North America Biosimilars Sales by Type (2017-2022) & (K MT)
Table 46. North America Biosimilars Sales by Type (2023-2028) & (K MT)
Table 47. North America Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Biosimilars Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Biosimilars Sales by Application (2017-2022) & (K MT)
Table 50. North America Biosimilars Sales by Application (2023-2028) & (K MT)
Table 51. North America Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Biosimilars Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Biosimilars Sales by Country (2017-2022) & (K MT)
Table 54. North America Biosimilars Sales by Country (2023-2028) & (K MT)
Table 55. North America Biosimilars Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Biosimilars Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Biosimilars Sales by Type (2017-2022) & (K MT)
Table 58. Europe Biosimilars Sales by Type (2023-2028) & (K MT)
Table 59. Europe Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Biosimilars Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Biosimilars Sales by Application (2017-2022) & (K MT)
Table 62. Europe Biosimilars Sales by Application (2023-2028) & (K MT)
Table 63. Europe Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Biosimilars Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Biosimilars Sales by Country (2017-2022) & (K MT)
Table 66. Europe Biosimilars Sales by Country (2023-2028) & (K MT)
Table 67. Europe Biosimilars Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Biosimilars Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Biosimilars Sales by Type (2017-2022) & (K MT)
Table 70. Asia Pacific Biosimilars Sales by Type (2023-2028) & (K MT)
Table 71. Asia Pacific Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Biosimilars Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Biosimilars Sales by Application (2017-2022) & (K MT)
Table 74. Asia Pacific Biosimilars Sales by Application (2023-2028) & (K MT)
Table 75. Asia Pacific Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Biosimilars Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Biosimilars Sales by Region (2017-2022) & (K MT)
Table 78. Asia Pacific Biosimilars Sales by Region (2023-2028) & (K MT)
Table 79. Asia Pacific Biosimilars Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Biosimilars Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Biosimilars Sales by Type (2017-2022) & (K MT)
Table 82. Latin America Biosimilars Sales by Type (2023-2028) & (K MT)
Table 83. Latin America Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Biosimilars Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Biosimilars Sales by Application (2017-2022) & (K MT)
Table 86. Latin America Biosimilars Sales by Application (2023-2028) & (K MT)
Table 87. Latin America Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Biosimilars Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Biosimilars Sales by Country (2017-2022) & (K MT)
Table 90. Latin America Biosimilars Sales by Country (2023-2028) & (K MT)
Table 91. Latin America Biosimilars Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Biosimilars Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Biosimilars Sales by Type (2017-2022) & (K MT)
Table 94. Middle East and Africa Biosimilars Sales by Type (2023-2028) & (K MT)
Table 95. Middle East and Africa Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Biosimilars Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Biosimilars Sales by Application (2017-2022) & (K MT)
Table 98. Middle East and Africa Biosimilars Sales by Application (2023-2028) & (K MT)
Table 99. Middle East and Africa Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Biosimilars Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Biosimilars Sales by Country (2017-2022) & (K MT)
Table 102. Middle East and Africa Biosimilars Sales by Country (2023-2028) & (K MT)
Table 103. Middle East and Africa Biosimilars Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Biosimilars Revenue by Country (2023-2028) & (US$ Million)
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 108. Pfizer Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Pfizer Recent Developments
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Major Businesses
Table 112. Novartis Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 113. Novartis Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Novartis Recent Developments
Table 115. Biocon Corporation Information
Table 116. Biocon Description and Major Businesses
Table 117. Biocon Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 118. Biocon Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Biocon Recent Developments
Table 120. Biogen Corporation Information
Table 121. Biogen Description and Major Businesses
Table 122. Biogen Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 123. Biogen Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Biogen Recent Developments
Table 125. Fresenius Kabi AG Corporation Information
Table 126. Fresenius Kabi AG Description and Major Businesses
Table 127. Fresenius Kabi AG Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 128. Fresenius Kabi AG Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Fresenius Kabi AG Recent Developments
Table 130. Boehringer Ingelheim Corporation Information
Table 131. Boehringer Ingelheim Description and Major Businesses
Table 132. Boehringer Ingelheim Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 133. Boehringer Ingelheim Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Boehringer Ingelheim Recent Developments
Table 135. Merck KgaA Corporation Information
Table 136. Merck KgaA Description and Major Businesses
Table 137. Merck KgaA Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 138. Merck KgaA Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Merck KgaA Recent Developments
Table 140. Mylan Corporation Information
Table 141. Mylan Description and Major Businesses
Table 142. Mylan Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 143. Mylan Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Mylan Recent Developments
Table 145. Eli Lilly Corporation Information
Table 146. Eli Lilly Description and Major Businesses
Table 147. Eli Lilly Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 148. Eli Lilly Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Eli Lilly Recent Developments
Table 150. Teva Pharmaceutical Corporation Information
Table 151. Teva Pharmaceutical Description and Major Businesses
Table 152. Teva Pharmaceutical Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 153. Teva Pharmaceutical Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Teva Pharmaceutical Recent Developments
Table 155. Dr. Reddy's Laboratories Corporation Information
Table 156. Dr. Reddy's Laboratories Description and Major Businesses
Table 157. Dr. Reddy's Laboratories Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 158. Dr. Reddy's Laboratories Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Dr. Reddy's Laboratories Recent Developments
Table 160. Amgen Corporation Information
Table 161. Amgen Description and Major Businesses
Table 162. Amgen Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 163. Amgen Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Amgen Recent Developments
Table 165. Celltrion Corporation Information
Table 166. Celltrion Description and Major Businesses
Table 167. Celltrion Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 168. Celltrion Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Celltrion Recent Developments
Table 170. Samsung Biologics Corporation Information
Table 171. Samsung Biologics Description and Major Businesses
Table 172. Samsung Biologics Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 173. Samsung Biologics Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Samsung Biologics Recent Developments
Table 175. Roche Corporation Information
Table 176. Roche Description and Major Businesses
Table 177. Roche Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 178. Roche Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Roche Recent Developments
Table 180. Probiomed Corporation Information
Table 181. Probiomed Description and Major Businesses
Table 182. Probiomed Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 183. Probiomed Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Probiomed Recent Developments
Table 185. Apotex Corporation Information
Table 186. Apotex Description and Major Businesses
Table 187. Apotex Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 188. Apotex Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Apotex Recent Developments
Table 190. Chong Kun Dang Corporation Information
Table 191. Chong Kun Dang Description and Major Businesses
Table 192. Chong Kun Dang Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 193. Chong Kun Dang Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Chong Kun Dang Recent Developments
Table 195. JCR Pharmaceuticals Corporation Information
Table 196. JCR Pharmaceuticals Description and Major Businesses
Table 197. JCR Pharmaceuticals Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 198. JCR Pharmaceuticals Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. JCR Pharmaceuticals Recent Developments
Table 200. Gan & Lee Pharmaceuticals Corporation Information
Table 201. Gan & Lee Pharmaceuticals Description and Major Businesses
Table 202. Gan & Lee Pharmaceuticals Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 203. Gan & Lee Pharmaceuticals Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 204. Gan & Lee Pharmaceuticals Recent Developments
Table 205. Gedeon Richter Corporation Information
Table 206. Gedeon Richter Description and Major Businesses
Table 207. Gedeon Richter Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 208. Gedeon Richter Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 209. Gedeon Richter Recent Developments
Table 210. Biocad Corporation Information
Table 211. Biocad Description and Major Businesses
Table 212. Biocad Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 213. Biocad Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 214. Biocad Recent Developments
Table 215. Coherus Bioscience Corporation Information
Table 216. Coherus Bioscience Description and Major Businesses
Table 217. Coherus Bioscience Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 218. Coherus Bioscience Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 219. Coherus Bioscience Recent Developments
Table 220. Stada Arzneimittel AG Corporation Information
Table 221. Stada Arzneimittel AG Description and Major Businesses
Table 222. Stada Arzneimittel AG Biosimilars Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 223. Stada Arzneimittel AG Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
Table 224. Stada Arzneimittel AG Recent Developments
Table 225. Key Raw Materials Lists
Table 226. Raw Materials Key Suppliers Lists
Table 227. Biosimilars Distributors List
Table 228. Biosimilars Customers List
Table 229. Biosimilars Market Trends
Table 230. Biosimilars Market Drivers
Table 231. Biosimilars Market Challenges
Table 232. Biosimilars Market Restraints
Table 233. Research Programs/Design for This Report
Table 234. Key Data Information from Secondary Sources
Table 235. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilars Product Picture
Figure 3. Global Biosimilars Market Share by Type in 2021 & 2028
Figure 3. Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Figure 4. Recombinant Glycosylated Proteins Product Picture
Figure 5. Global Biosimilars Market Share by Application in 2021 & 2028
Figure 6. Oncology
Figure 7. Blood Disorders
Figure 8. Growth Hormonal Deficiency
Figure 9. Chronic and Autoimmune Disorders
Figure 10. Others
Figure 11. Biosimilars Report Years Considered
Figure 12. Global Biosimilars Sales 2017-2028 (K MT)
Figure 13. Global Biosimilars Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Biosimilars Revenue 2017-2028 (US$ Million)
Figure 15. Global Biosimilars Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Biosimilars Sales Market Share by Region (2017-2022)
Figure 17. Global Biosimilars Sales Market Share by Region (2023-2028)
Figure 18. North America Biosimilars Sales YoY (2017-2028) & (K MT)
Figure 19. North America Biosimilars Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Biosimilars Sales YoY (2017-2028) & (K MT)
Figure 21. Europe Biosimilars Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Biosimilars Sales YoY (2017-2028) & (K MT)
Figure 23. Asia-Pacific Biosimilars Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Biosimilars Sales YoY (2017-2028) & (K MT)
Figure 25. Latin America Biosimilars Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Biosimilars Sales YoY (2017-2028) & (K MT)
Figure 27. Middle East & Africa Biosimilars Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Biosimilars Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Biosimilars in the World: Market Share by Biosimilars Revenue in 2021
Figure 30. Global Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Biosimilars Sales Market Share by Type (2017-2028)
Figure 32. Global Biosimilars Revenue Market Share by Type (2017-2028)
Figure 33. Global Biosimilars Sales Market Share by Application (2017-2028)
Figure 34. Global Biosimilars Revenue Market Share by Application (2017-2028)
Figure 35. North America Biosimilars Sales Market Share by Type (2017-2028)
Figure 36. North America Biosimilars Revenue Market Share by Type (2017-2028)
Figure 37. North America Biosimilars Sales Market Share by Application (2017-2028)
Figure 38. North America Biosimilars Revenue Market Share by Application (2017-2028)
Figure 39. North America Biosimilars Sales Share by Country (2017-2028)
Figure 40. North America Biosimilars Revenue Share by Country (2017-2028)
Figure 41. U.S. Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Biosimilars Sales Market Share by Type (2017-2028)
Figure 44. Europe Biosimilars Revenue Market Share by Type (2017-2028)
Figure 45. Europe Biosimilars Sales Market Share by Application (2017-2028)
Figure 46. Europe Biosimilars Revenue Market Share by Application (2017-2028)
Figure 47. Europe Biosimilars Sales Share by Country (2017-2028)
Figure 48. Europe Biosimilars Revenue Share by Country (2017-2028)
Figure 49. Germany Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 50. France Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Biosimilars Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Biosimilars Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Biosimilars Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Biosimilars Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Biosimilars Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Biosimilars Revenue Share by Region (2017-2028)
Figure 60. China Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 63. India Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Biosimilars Sales Market Share by Type (2017-2028)
Figure 70. Latin America Biosimilars Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Biosimilars Sales Market Share by Application (2017-2028)
Figure 72. Latin America Biosimilars Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Biosimilars Sales Share by Country (2017-2028)
Figure 74. Latin America Biosimilars Revenue Share by Country (2017-2028)
Figure 75. Mexico Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Biosimilars Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Biosimilars Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Biosimilars Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Biosimilars Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Biosimilars Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Biosimilars Revenue Share by Country (2017-2028)
Figure 84. Turkey Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Biosimilars Revenue (2017-2028) & (US$ Million)
Figure 87. Biosimilars Value Chain
Figure 88. Biosimilars Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Novartis Biocon Biogen Fresenius Kabi AG Boehringer Ingelheim Merck KgaA Mylan Eli Lilly Teva Pharmaceutical Dr. Reddy's Laboratories Amgen Celltrion Samsung Biologics Roche Probiomed Apotex Chong Kun Dang JCR Pharmaceuticals Gan & Lee Pharmaceuticals Gedeon Richter Biocad Coherus Bioscience Stada Arzneimittel AG